Search
Close this search box.

Manufacturing

Clatan has a vast manufacturing platform in India which comprises active pharmaceutical ingredient (API), oral solid dose (OSD) and injectables facilities that serve a number of markets around the world and produce medicines in a wide range of therapeutic areas.

Clatan’s has facilities in India, including all of its API facilities, are approved by the U.S. Food and Drug Administration (FDA). Many of these sites also are approved and regularly inspected by other regulatory authorities, including Australia’s Therapeutic Goods Administration, the U.K.’s Medicines and Healthcare Products Regulatory Agency and the World Health Organization.

Dosage Forms

Syrups
Immediate-release tablets
Sachet filled with powder
Modified-release tablets
Soft gel
Capsules filled with powder and pellets
Injectables

Packaging Capabilities

Manufacturing Capabilities

Bi-Layered Tablets
Capsules banding
Direct compression
Dry granulation
Extrusion spherization
Fluid bed drier
Hot melt extrusion
Laser drilling
Multiple-unit pellet system
Pellets and beads
Roller compaction
Solid drug layering
Tablet coater
Wet granulation
Soft gel
Syrups
Injectables
Extrusion spherization
Pellets and beads
Wurster coater with capability to handle solvents
Soft gel